Pricing Log in Create free account

Olema Pharmaceuticals, Inc. (OLMA) vs WAVE Life Sciences Ltd. (WVE)

Olema Pharmaceuticals, Inc. and WAVE Life Sciences Ltd. are both Biotechnology companies. Olema Pharmaceuticals, Inc. and WAVE Life Sciences Ltd. are of similar size ($628.6M and $601.1M). Olema Pharmaceuticals, Inc. has the higher net margin (0.00% vs −309.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Olema Pharmaceuticals, Inc. leads on 9 and WAVE Life Sciences Ltd. on 4.

Valuation

Metric OLMA WVE Biotechnology median
P/E n/m n/m 8.50
P/S n/m 9.74 9.71
P/B 1.60 1.40 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.23 9.21
Earnings yield (32.22%) (34.94%) (33.15%)
Free cash flow yield (24.00%) (30.34%) (25.50%)

Profitability

Metric OLMA WVE Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (333.36%) 0.00%
Net margin 0.00% (309.73%) 0.00%
Free cash flow margin 0.00% (295.46%) 0.00%
Return on equity (52.74%) (68.31%) (56.36%)
Return on assets (47.10%) (49.95%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OLMA WVE Biotechnology median
Revenue growth (TTM) — (30.42%) 6.02%
EPS growth (last fiscal year) 15.00% (72.86%) 30.26%
Revenue growth, 5-year CAGR — 16.31% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OLMA WVE Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 8.86 9.99 4.72
Net debt to EBITDA 2.82 2.92 0.96

Dividend

Metric OLMA WVE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OLMA WVE Biotechnology median
Market cap 601.10m 628.58m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack